Published March 20, 2015 | Version v1
Journal article Open

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus

Authors/Creators

  • 1. Odessa National Medical University

Description

Poniatowskaya T. Yu. Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus. Journal of Education, Health and Sport. 2015;5(3):55-61. ISSN 2391-8306. DOI: 10.5281/zenodo.16210

http://ojs.ukw.edu.pl/index.php/johs/article/view/2015%3B5%283%29%3A55-61

https://pbn.nauka.gov.pl/works/547306

http://dx.doi.org/10.5281/zenodo.16210

Formerly Journal of Health Sciences. ISSN 1429-9623 / 2300-665X. Archives 2011 – 2014 http://journal.rsw.edu.pl/index.php/JHS/issue/archive

 

Deklaracja.

Specyfika i zawartość merytoryczna czasopisma nie ulega zmianie.

Zgodnie z informacją MNiSW z dnia 2 czerwca 2014 r., że w roku 2014 nie będzie przeprowadzana ocena czasopism naukowych; czasopismo o zmienionym tytule otrzymuje tyle samo punktów co na wykazie czasopism naukowych z dnia 31 grudnia 2014 r.

The journal has had 5 points in Ministry of Science and Higher Education of Poland parametric evaluation. Part B item 1089. (31.12.2014).

© The Author (s) 2015;

This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland and Radom University in Radom, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,

provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License

(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial

use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

Received: 20.01.2014. Revised 27.02.2015. Accepted: 12.03.2015.

 

EFFECT OF ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM AT THE RESULTS OF LOSARTAN USE IN

THE PATIENTS WITH TYPE 2 DIABETES MELLITUS

 

T. Yu. Poniatowskaya

 

Odessa National Medical University

 

Summary

The article presented is an original investigation where the effects of losartan in patients with hypertension and type 2 diabetes mellitus (T2DM) have been evaluated. The effect of therapy has been estimated with the help of gene ACE allelic variant. The dependence of enalapril antihypertensive action and nephroprotective action of ACE polymorphism has been revealed. The results obtained show a different effect on ACE allele variants of lipid metabolism in patients with hypertension and T2DM and complications in the form of hypertriglyceridemia in the patients with DD-genotype.

 

Key words: type 2 diabetes mellitus, hypertension, I / D polymorphism of the gene ACE, pharmacogenetics, losartan.

Notes

Poniatowskaya T. Yu. Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus. Journal of Education, Health and Sport. 2015;5(3):55-61. ISSN 2391-8306. DOI: 10.5281/zenodo.16210 http://ojs.ukw.edu.pl/index.php/johs/article/view/2015%3B5%283%29%3A55-61 https://pbn.nauka.gov.pl/works/547306 http://dx.doi.org/10.5281/zenodo.16210

Files

2015_5_3_55-61_2580.pdf

Files (225.7 kB)

Name Size
md5:51ad6420587029bdd453809b4fa7a298
225.7 kB Preview Download

Additional details

Related works

Is supplement to
http://ojs.ukw.edu.pl/index.php/johs/article/view/2015%3B5%283%29%3A55-61 (URL)
https://pbn.nauka.gov.pl/works/547306 (URL)
10.5281/zenodo.16210 (DOI)

References

  • 1. P.K. Jacobsen. Preventing and stage renal disease in diabetic patients - genetic aspect. Journal of the Renin-Angiotensin-Aldosterone System 2005; 6: 1-14.
  • 2. P. Ruggenenti, P.Cravedi, G, Remuzzi. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat. Rev. nephrol. 6, 319-330 (2010).
  • 3. G. Braliou, A.G. Grigoriadou, P.I. Kontou, P.G. Bagos. The role of genetic polymorphisms of the reninb-angiotensin system in trenal diseases: a meta-analysis. Computational ands Structural Biotechnology Journal 10 (2014) 1-7.
  • 4. M. Zivko et al. Impact of Angiotensin-Converting Enzyme gene polymorphism on proteinuria and arterial hypertension. Coll. Antropol. 37 (2013) 3: 765-770. (Rus.)
  • 5. H.E.Roytberh, Zh.V.Dorosh, Ye.V.Aksonov, T.I.Ushakova. Effect of polymorphism of angiotensin-converting enzyme on the occurrence of insulin resistance syndrome. Clinician. -№2,2013 - P. 14-17 (Rus.).
  • 6. Haque S.F. et al. ACE insertion / deletion gene polymorphism determines efficacy of telmisartan: an ARB in type 2 diabetic nephropathy. Journal of cell and tissue research. 2011. - Vol.11 (1): 2595-2600.
  • 7. Cooper Worobey C., Fisher NDL, Cox D, Forman JP, Curhan GC. Genetic polymorphisms and the risk of accelerated renal function decline in women. PLoS ONE 4 (3): e4787. doi: 10.1371 / journal.pone.0004787.
  • 8. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplement. - 2013. - №3. - R.1-150.
  • 9. AE Dubenko, VV Hvysyuk, SL Kostyukovsky, T.V.Danko. Microalbuminuria and gene polymorphism of angiotensin-converting enzyme inhibitors in patients with acute stroke. Problems of Continuing Education and Science of Ukraine. - №1, 2014. - P.38-41 (Ukr.).